
More than 3.5 million people in the UK live with a rare condition

The deal will expand Shionogi’s growing portfolio with IntraBio’s rare diseases capabilities

Desmoid tumours are rare soft tissue tumours that can grow aggressively into nearby tissues

Godfrey previously served as Head of Medical for Respiratory and Immunology for AstraZeneca UK

The company will pay $435m in up front and near-term milestone payments

The acquisition will advance innovation for patients with rare skin diseases

The rare disease affects around one in every 22,000 people worldwide

By Lottie Sequerra and Emily Morton-West

The insulin is designed as an alternative to daily basal insulin

The elected employee representatives will join the Board of Directors after the annual general meeting on 26 March 2026

Construction is expected to be completed in phases from the end of 2027 into 2028

The companies aim to develop next-generation oral medicines for obesity and diabetes